Eric Zollars MD, PhD

Executive Medical Director @ Allogene Therapeutics

About

I am a passionate and enthusiastic advocate for the development of new therapeutics and approaches for the treatment of inflammatory diseases. We must work to get the right treatments to the right patients every time to prevent the destructive effects of inflammatory diseases and their current treatments. I am also a big believer in the power of real world evidence and big data to inform our approaches from the earliest phases of biomarker development all the way through clinical trial design and site and patient identification.

Country

United States

City

Ventura County

Industry

Biotechnology

Skill

Executive Level Management, Drug Development, Rheumatology, Clinical Research, Medical Education, Medicine, Internal Medicine, Hospitals, Public Health, Healthcare Management, Board Certified, Healthcare

Experience

Executive Medical Director

Allogene Therapeutics

2024-10 - Present · 2 yrs

San Francisco Bay Area

Development of novel CAR T therapies for autoimmune disease

Senior Medical Director

Gilead Sciences

2023-1 - 2024-10 · 1 yr 10 mos

Foster City, California, United States

Clinical development lead in multiple areas of inflammation including IBD, RA and SLE. Design and execution of early and mid-phase clinical trials.

Medical Director

Amgen

2020-3 - 2022-12 · 2 yrs 10 mos

Thousand Oaks, CA

Early Development Lead on multiple assets including neurology and NASH. Early development member of Global Development Phase 2 in SLE. Active member of all SLE efforts including Real World Data projects and Human Data initiatives. Multiple Business Development projects including advising on Tavneos (Chemocentryx) and Horizon acquisitions.

Physician

Medical University of South Carolina

2014-7 - 2020-3 · 5 yrs 9 mos

Charleston, South Carolina Area

Attending physician in the Rheumatology Division. Member of the MUSC Lupus group and Investigator on multiple industry-funded interventional trials. Ran an active Rheumatology clinic at the East Cooper location. Taught residents and fellows. Performed Investigator-initiated research with gene expression analysis of lupus disease activity and MRI investigation of lupus arthritis.